Nagasaki University

Nagasaki University and NEC OncoImmunity Collaborate to Design Universal Vaccines Targeting Tropical Infectious Diseases

Retrieved on: 
Monday, August 21, 2023
NEC, Vaccine, Drug development, Tropical medicine, Health care, Global health, Infection, Research, Attention, National Exhibition Centre, Interdisciplinarity, Institute for Tropical Medicine Tübingen, Artificial intelligence, NOI, Knowledge, Nagasaki University, AI, Medical device

TOKYO, Aug 21, 2023 - (JCN Newswire) - Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, have announced that they will collaborate to use NOI's AI platform to design universal vaccines against highly pathogenic and tropical infectious diseases.

Key Points: 
  • TOKYO, Aug 21, 2023 - (JCN Newswire) - Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, have announced that they will collaborate to use NOI's AI platform to design universal vaccines against highly pathogenic and tropical infectious diseases.
  • Under the scope of the collaboration, the AI technology from NOI will be used to design both T cell and B cell vaccines.
  • This collaboration has also led to the establishment of the Vaccine Informatics Department at the Institute of Tropical Medicine, Nagasaki University.
  • "We are delighted to embark on this collaboration with NEC OncoImmunity in our pursuit of designing universal vaccines targeting tropical infectious diseases.

Global health leaders adopt the Nagasaki Outcomes Statement and jointly call for the acceleration of R&D, access and delivery for neglected tropical diseases

Retrieved on: 
Tuesday, July 4, 2023
Vaccine, Acceleration, AVC, Neglected tropical diseases, Therapy, Primary health care, PHC, Combat, Kigali Declaration on Neglected Tropical Diseases, 2020 extraordinary G20 summit on COVID-19, 47th G7 summit, Research, PDP-8, G7, Organization, Research and development, Development, UHC, Capacity building, Investment, NTD, Access, Knowledge, Delivery, Nagasaki University, UNGA, Ecosystem, Statement, WHO, R, World Health Organization, Mobile phone, Renewable energy, Consultant, Appendix

TOKYO, July 4, 2023 /PRNewswire/ -- Today, leading organizations signed and adopted the "Nagasaki Outcomes Statement," which calls for accelerated R&D, access and delivery for neglected tropical diseases (NTDs).

Key Points: 
  • TOKYO, July 4, 2023 /PRNewswire/ -- Today, leading organizations signed and adopted the "Nagasaki Outcomes Statement," which calls for accelerated R&D, access and delivery for neglected tropical diseases (NTDs).
  • To address this challenge, global health leaders convened at the Commemorative Symposium for G7 Health Ministers Meeting in Nagasaki, Japan, "Accelerating Research and Development, Access and Delivery for Neglected Tropical Diseases," to agree to the "Nagasaki Outcomes Statement" and call for sustainable financing and equitable access to interventions for NTDs.
  • In addition to six asks to G7 Leaders to support investments in R&D, access and delivery, the Statement recognizes that there is a key role for the global NTD community to play.
  • Connect, coordinate and create a multisectoral approach, enabling end-to-end ecosystem for the acceleration of R&D, access and delivery.

Nagasaki University Presented Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19

Retrieved on: 
Thursday, May 11, 2023
Science, Research, Pharmaceutical, Health, COVID-19, University, Education, Clinical Trials, Vaccine, First Department, Smell, Kirin Holdings, Food, Anosmia, Rotavirus, Shortness, Headache, SARS-CoV-2, PDC, Consumer Affairs Agency, Clinical trial, Infection, Division, Multimedia, Chest pain, Fatigue, Lactococcus lactis, Pandemic, Patient, Patent, Risk, Fever Dream, Immune system, Internal medicine, Randomized controlled trial, Blood, Viral load, Shortness of breath, Nagasaki University, Cough, Respiratory Medicine, Institute for Plasma Research, Safety, Pharmaceutical industry, Copper, Omicron, Kirin, Anorexia nervosa, Dysgeusia, Limited, Immunity, Lactococcus, Plasma

Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus.

Key Points: 
  • Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus.
  • lactis strain Plasma*1 (L.lactis Plasma, a postbiotic), researched and developed by Kirin Holdings Company, Limited (Kirin Holdings).
  • Nagasaki University and Kirin Holdings have jointly filed a patent application for the findings of this specified clinical trial.
  • Nagasaki University and Kirin hope that L. lactis Plasma will become one of the new treatment or adjunctive care to patients with mild COVID-19.

KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya

Retrieved on: 
Tuesday, February 7, 2023
Data Management, Technology, University, Education, Biometrics, Hospitals, Children, Baby, Maternity, Clinical Trials, Science, Software, Networks, Consumer, Health, Research, Caregiver, Voice recognition, Human voice, NEC, Life, Hand, Hospital, Kinango, Vaccination, Electricity, Digital technology, Clinical trial, Kenya Medical Research Institute, Telecommunications, Nagasaki University, KEMRI, Death, Pharmaceutical industry, Vaccine

The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.

Key Points: 
  • The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.
  • Validation of this system is taking place through KEMRI with a clinical trial that began in September 2022 at the Kinango Sub-County Hospital in Kwale.
  • The digital system being provided by NEC, a leader in the integration of IT and network technologies, and KEMRI, one of Africa’s leading research Institutions, will effectively and seamlessly manage vaccination history and scheduling using fingerprint identification for newborn children and voice recognition for caregivers.
  • This technology marks the first time that biometric identification is being used at a hospital to identify newborn children at the time of vaccination, including those immediately after delivery (*1).

transcosmos will open a new center in the office tower of Nagasaki Stadium City

Retrieved on: 
Thursday, February 9, 2023
Postgraduate education, The Center of Applied Data Science, BPO, Eye, Research, Data science, Business process, City, Nagasaki University, Growth, Digital transformation, COVID-19, AI, Transcosmos Stadium Nagasaki, DX, Satellite navigation device, Industrial design, Kerosene

TOKYO, Feb. 9, 2023 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company will open a new center in the office tower in Nagasaki Stadium City, which is scheduled to open in 2024.

Key Points: 
  • TOKYO, Feb. 9, 2023 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company will open a new center in the office tower in Nagasaki Stadium City, which is scheduled to open in 2024.
  • transcosmos has decided to open its center in the office tower of the stadium city.
  • transcosmos inc. has announced that the company will open a new center, a flagship center that will offer BPO-DX combined services, in the office tower of Nagasaki Stadium City.
  • transcosmos inc. opened the BPO Center Nagasaki in 2015, followed by the second center, the BPO Center Nagasaki Chuo in 2020.

KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya

Retrieved on: 
Tuesday, February 7, 2023
Universal health care, Caregiver, Kinango, Nagasaki University, Hand, NEC, Death, SDG, Human, Child, Telecommunication, Life, Guideline, Hospital, Partnership, Finger, Medicine, Biometrics, KEMRI, COVID-19, Policy, Vaccine, Kenya Medical Research Institute, Mother, Digital technology, Name, Report, Hospital Records, Clinical trial, Mortality, Voice recognition, Electricity, Classification, Vaccination, Sustainable Development Goals, Research, Pharmaceutical industry, Security printing, Residential care

TOKYO, Feb 7, 2023 - (JCN Newswire) - Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC) and Nagasaki University, Japan, have developed a digital biometric-based vaccination management system for newborn children in Kenya.

Key Points: 
  • TOKYO, Feb 7, 2023 - (JCN Newswire) - Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC) and Nagasaki University, Japan, have developed a digital biometric-based vaccination management system for newborn children in Kenya.
  • This technology marks the first time that biometric identification is being used at a hospital to identify newborn children at the time of vaccination, including those immediately after delivery(1).
  • As of November 2022, data from more than 300 caregivers and newborns had been registered, including the vaccination histories of more than 150 newborns.
  • (1) NEC research as of February 7, 2023
    (2) Source: Levels and trends in child mortality, Report 2021, UN-IGME

Kuke Music Announces Change of Independent Director

Retrieved on: 
Tuesday, September 20, 2022
University, Capital University of Medical Sciences, Nagasaki University, Efficiency, NYSE, Company, Library, Beijing Music Festival, Student, Seychelles Tourism Board, Board, Music, Marketing

BEIJING, Sept. 20, 2022 /PRNewswire/ --Kuke Music Holding Limited ("Kuke" or the "Group") (NYSE: KUKE), a leading classical music service platform in China, announced the replacement of an independent director, effective as of September 20, 2022.

Key Points: 
  • BEIJING, Sept. 20, 2022 /PRNewswire/ --Kuke Music Holding Limited ("Kuke" or the "Group") (NYSE: KUKE), a leading classical music service platform in China, announced the replacement of an independent director, effective as of September 20, 2022.
  • Kuke is a leading classical music service platform in China encompassing the entire value chain from content provision to music learning services.
  • Leveraging its market leadership in international copyrighted classical music content, Kuke provides highly scalable classical music licensing services to various online music platforms, and classical music subscription services to over 800 universities, libraries and other institutions across China.
  • Through KUKEY, the Company's proprietary AI music learning system, Kuke aims to democratize music learning via technological innovation, bring fascinating music content and professional music techniques to more students, and continuously improve the efficiency and penetration of music learning in China.

Kyocera and Nagasaki University Develop “Energy Harvesting Smart Buoy” to Collect Ocean Data

Retrieved on: 
Wednesday, August 25, 2021
Technology, Mobile, Wireless, Other Energy, Manufacturing, Energy, Other Science, University, Environment, Education, Internet, Hardware, Science, Other Manufacturing, Data Management, Oxygen, University, IOT, GPS, Small, Nagasaki University, Aquaculture, VTT, Humidity, Multimedia, Data collection, GLONASS, Quasi-Zenith Satellite System, Water, Climate change, Power, Rotation, Renewable energy, Dam, Satellite navigation device

Nagasaki University (President: Shigeru Kohno) and Kyocera Corporation (President: Hideo Tanimoto) announced their joint development of an Energy Harvesting Smart Buoy, which combines Nagasaki University's tidal current power generation technology with Kyocera's IoT technology to collect reliable ocean data.

Key Points: 
  • Nagasaki University (President: Shigeru Kohno) and Kyocera Corporation (President: Hideo Tanimoto) announced their joint development of an Energy Harvesting Smart Buoy, which combines Nagasaki University's tidal current power generation technology with Kyocera's IoT technology to collect reliable ocean data.
  • Prototype buoys can collect a wide range of data on the marine environment using self-generated energy.
  • Therefore, Nagasaki University and Kyocera developed the "Energy Harvesting Smart Buoy," which generates its own electric power for continuous ocean data collection using a tidal-current power generation system in the buoy.
  • The new Smart Buoy combines tidal-current power generation technology from Nagasaki University and IoT-related technology from Kyocera.